50% of the global population is infected by H.pylori

The Helicobacter Foundation. Epidemiology. (accessed on 1 March 2013)

H. PYLORI IS ASSOCIATED WITH A NUMBER OF GASTROINTENSIAL DISEASES

• Peptic ulcer disease (1)

• Gastric cancer (1)

• Inflammatory response ant type-B gastritis (2)

1. Ford A.C., Axon A.T. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2010;15:1–6. doi: 10.1111/j.1523-5378.2010.00779.x

2. Felley C., Michetti P. Probiotics and Helicobacter pylori. Best Pract. Res. Clin. Gastroenterol. 2003;17:785–791. doi: 10.1016/S1521-6918(03)00070-2.

Today's treatment of H.Pylori is based on  antibiotic cocktail and anti-acids that can cause adverse reaction like: 

• Bloating

• Diarrhea

• IBS (Irritable bowel syndrome).

• Osteoporosis (with chronic user of anti acid)

PYLO-X THE NATURAL WAY TO SUPPORT HEALTHY STOMACH ENVIRONMENT*

• Contains Pylopass™ that has been scientifically tested to help manage the presence of H. pylori in the stomach

• Specificity for H. pylori - While probiotics cater to general gut health, Pylopass™ specifically binds H. pylori in the stomach. Because of the specific nature of its activities in the gut, Pylopass™ does not bind or otherwise disturb the overall normal gut microbial balance

• Natural ingredients

• No side effect

*This statement has not been evaluted by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any diseases.

HOW DOES IT WORK

PYLO-X CONTAINS PYLOPASS™ WHICH IS A SPECIAL STRAIN OF LACTOBACILLUS REUTERI, THAT WAS ISOLATED BY ADVANCED TECHNOLOGY, BECAUSE OF ITS ANTI-H. PYLORI CHARACTERISTICS.

CLINICAL STUDIES SHOW REDUCTION IN UREASE BREATH TEST AFTER USING PYLOPASS™.     

​

Research

Phone: 833.550.6660